Ochron Pharma Private Limited
About Ochron Pharma Private Limited
Data last updated:
Ochron Pharma Private Limited is a private limited company based in Patiali, Uttar Pradesh, India. It was incorporated on 28 March 2023.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U46909UP2023PTC179114. Its GSTIN is 09AAECO0223E1ZX (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹25,000. It is led by directors including Mohammad Shahan and Mohammad Salman.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Patiali, Uttar Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.36 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹6.04 Lakh (net margin 4.4%) and EBITDA of ₹8.24 Lakh (EBITDA margin 6.1%).
Company details
Contact details
Ochron Pharma Private Limited's registered office is in Patiali, Uttar Pradesh.
- Registered AddressC/O Mohammad Farhan Ganeshpur, Kanshiram Nagar Kasganj, Patiali, Uttar Pradesh, India – 207242
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ochron Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Ochron Pharma Private Limited, buy the company report.
Financials of Ochron Pharma Private Limited
FY 2025 filings availableOchron Pharma Private Limited reported revenue of ₹1.36 Cr (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year. EBITDA rose 11% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹8.24 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹6.04 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 6.1% | ||
| Net Profit Margin | 4.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Ochron Pharma Private Limited, buy the company report.
Board of directors of Ochron Pharma Private Limited
Ochron Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohammad Shahan | Director | 28 Mar 2023 | 3 Years 6 Months | Current |
| Mohammad Salman | Director | 28 Mar 2023 | 3 Years 6 Months | Current |
| Mohammad Farhan | Director | 28 Mar 2023 | 3 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Ochron Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ochron Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ochron Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECO0223E1ZX | Uttar Pradesh | Active | 09 May 2023 |
To see the full GST registrations and return filing status of Ochron Pharma Private Limited, buy the company report.
Recent activity
Ochron Pharma Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Mohammad Farhan was appointed as Director on 28 Mar 2023.
Frequently asked questions
Ochron Pharma is an active private limited company based in Patiali, Uttar Pradesh, India. It was incorporated on 28 March 2023 (3+ years old) and is registered under CIN U46909UP2023PTC179114.
Ochron Pharma has 3 current directors:
- Mohammad Shahan - Director
- Mohammad Salman - Director
- Mohammad Farhan - Director
The latest financial statements of Ochron Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Ochron Pharma is 09AAECO0223E1ZX, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ochron Pharma is U46909UP2023PTC179114. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ochron Pharma was incorporated on 28 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Mohammad Farhan was appointed as Director on 28 Mar 2023. Mohammad Salman was appointed as Director on 28 Mar 2023. Mohammad Shahan was appointed as Director on 28 Mar 2023.
The registered office of Ochron Pharma is at CO Mohammad Farhan Ganeshpur, Kanshiram Nagar Kasganj, Patiali, Uttar Pradesh, India – 207242.
Ochron Pharma can be reached at its registered office: CO Mohammad Farhan Ganeshpur, Kanshiram Nagar Kasganj, Patiali, Uttar Pradesh, India – 207242.
Ochron Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Uttar Pradesh.